Our partners

From biotech startups to commercial partners to partners in oncology and urology, join the ever-growing community working with Photocure

In-licensing

Combat Medical

In August 2018, Photocure entered into an exclusive distribution deal for the Nordic area with Combat Medical Ltd for distribution of their patented medical device. This innovative and highly automated device delivers heated therapy to bladder cancer patients.
This link will direct you to a site outside of Photocure

Out-licensing

Asieris Meditech Co., Ltd

In July 2019, Photocure entered into a License Agreement providing Asieris Meditech Co., Ltd (Asieris) with a world-wide license to develop and commercialize Cevira® for the treatment of HPV induced cervical precancerous lesions. In addition, in January 2021 Asieris has obtained exclusive rights from Photocure to register and commercialize Hexvix® in Mainland China and Taiwan.
This link will direct you to a site outside of Photocure

Genotests SpA

In August 2020, Photocure appointed Genotests SpA, a privately held company founded in 2014 specializing in genetic tests for cancer targeting cancer specialists, as the exclusive distributor for the commercialization of Hexvix® in Chile.

Endotherapeutics Group

In Q1 2022, Photocure entered into an exclusive distribution agreement with Endotherapeutics Group for the commercialization of Hexvix® in Australia and New Zealand.
This link will direct you to a site outside of Photocure

News and Events